Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IODIXANOL vs IPRAGLIFLOZIN L-PROLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IODIXANOL vs IPRAGLIFLOZIN L-PROLINE: Safety Overview

Metric IODIXANOL IPRAGLIFLOZIN L-PROLINE
Total FAERS Reports 2,068 124
Deaths Reported 140 9
Death Rate 6.8% 7.3%
Hospitalizations 740 74
Average Patient Age 61.5 yrs 62.1 yrs
% Female Patients 49.4% 37.6%
FDA Approval Date Aug 29, 1997 N/A
Manufacturer FRESENIUS KABI USA, LLC N/A
Route INTRAVASCULAR N/A
Marketing Status Prescription N/A